Impact Factor 4.137 | CiteScore 4.28
More on impact ›
The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health professionals in the field of oncology, to reduce cancer prevalence and mortality.
We are especially interested in research that has a practical application to the study of public health problems. The application of various risk factor assessments for the planning of clinical trials and preventive interventions is of particular interest. Descriptive and analytical epidemiology and biochemical, microbiological, molecular, genetic, clinical medicine, and histopathological approaches are likewise welcome.
Topics of interest include but are not limited to:
While we welcome meta-analyses and descriptive studies, these should be based on statistical methods or systematic reviews and should bring new insights into the mechanisms of carcinogenesis.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Cancer Epidemiology and Prevention welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Cancer Epidemiology and Prevention, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Cancer Epidemiology and Prevention will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com